The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Particle Therapy Market Research Report 2025
Synopsis
Particle therapy is a form of external beam radiotherapy using beams of energetic protons, neutrons, or positive ions for cancer treatment. The most common type of particle therapy is proton therapy.
The global Particle Therapy market was valued at US$ 768.8 million in 2023 and is anticipated to reach US$ 1106.1 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Particle Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Particle Therapy.
Report Scope
The Particle Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Particle Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Particle Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Varian Medical Systems
Ion Beam Applications Sa (IBA)
Mevion Medical Systems, Inc.
Provision Healthcare, LLC
Sumitomo Heavy Industries, Ltd.
Hitachi, Ltd.
Optivus Proton Therapy, Inc.
Protom International, Inc.
Advanced Oncotherapy PLC.
Danfysik A/S
Segment by Type
Proton Therapy
Heavy Ion Therapy
Segment by Application
Pediatric Cancer
Prostate Cancer
Breast Cancer
Lung Cancer
Head and Neck Cancer
Other Cancers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Particle Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Particle therapy is a form of external beam radiotherapy using beams of energetic protons, neutrons, or positive ions for cancer treatment. The most common type of particle therapy is proton therapy.
The global Particle Therapy market was valued at US$ 768.8 million in 2023 and is anticipated to reach US$ 1106.1 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Particle Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Particle Therapy.
Report Scope
The Particle Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Particle Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Particle Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Varian Medical Systems
Ion Beam Applications Sa (IBA)
Mevion Medical Systems, Inc.
Provision Healthcare, LLC
Sumitomo Heavy Industries, Ltd.
Hitachi, Ltd.
Optivus Proton Therapy, Inc.
Protom International, Inc.
Advanced Oncotherapy PLC.
Danfysik A/S
Segment by Type
Proton Therapy
Heavy Ion Therapy
Segment by Application
Pediatric Cancer
Prostate Cancer
Breast Cancer
Lung Cancer
Head and Neck Cancer
Other Cancers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Particle Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Particle Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Proton Therapy
1.2.3 Heavy Ion Therapy
1.3 Market by Application
1.3.1 Global Particle Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pediatric Cancer
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Lung Cancer
1.3.6 Head and Neck Cancer
1.3.7 Other Cancers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Particle Therapy Market Perspective (2019-2030)
2.2 Particle Therapy Growth Trends by Region
2.2.1 Global Particle Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Particle Therapy Historic Market Size by Region (2019-2024)
2.2.3 Particle Therapy Forecasted Market Size by Region (2025-2030)
2.3 Particle Therapy Market Dynamics
2.3.1 Particle Therapy Industry Trends
2.3.2 Particle Therapy Market Drivers
2.3.3 Particle Therapy Market Challenges
2.3.4 Particle Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Particle Therapy Players by Revenue
3.1.1 Global Top Particle Therapy Players by Revenue (2019-2024)
3.1.2 Global Particle Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Particle Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Particle Therapy Revenue
3.4 Global Particle Therapy Market Concentration Ratio
3.4.1 Global Particle Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Particle Therapy Revenue in 2023
3.5 Particle Therapy Key Players Head office and Area Served
3.6 Key Players Particle Therapy Product Solution and Service
3.7 Date of Enter into Particle Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Particle Therapy Breakdown Data by Type
4.1 Global Particle Therapy Historic Market Size by Type (2019-2024)
4.2 Global Particle Therapy Forecasted Market Size by Type (2025-2030)
5 Particle Therapy Breakdown Data by Application
5.1 Global Particle Therapy Historic Market Size by Application (2019-2024)
5.2 Global Particle Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Particle Therapy Market Size (2019-2030)
6.2 North America Particle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Particle Therapy Market Size by Country (2019-2024)
6.4 North America Particle Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Particle Therapy Market Size (2019-2030)
7.2 Europe Particle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Particle Therapy Market Size by Country (2019-2024)
7.4 Europe Particle Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Particle Therapy Market Size (2019-2030)
8.2 Asia-Pacific Particle Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Particle Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Particle Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Particle Therapy Market Size (2019-2030)
9.2 Latin America Particle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Particle Therapy Market Size by Country (2019-2024)
9.4 Latin America Particle Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Particle Therapy Market Size (2019-2030)
10.2 Middle East & Africa Particle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Particle Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Particle Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Varian Medical Systems
11.1.1 Varian Medical Systems Company Detail
11.1.2 Varian Medical Systems Business Overview
11.1.3 Varian Medical Systems Particle Therapy Introduction
11.1.4 Varian Medical Systems Revenue in Particle Therapy Business (2019-2024)
11.1.5 Varian Medical Systems Recent Development
11.2 Ion Beam Applications Sa (IBA)
11.2.1 Ion Beam Applications Sa (IBA) Company Detail
11.2.2 Ion Beam Applications Sa (IBA) Business Overview
11.2.3 Ion Beam Applications Sa (IBA) Particle Therapy Introduction
11.2.4 Ion Beam Applications Sa (IBA) Revenue in Particle Therapy Business (2019-2024)
11.2.5 Ion Beam Applications Sa (IBA) Recent Development
11.3 Mevion Medical Systems, Inc.
11.3.1 Mevion Medical Systems, Inc. Company Detail
11.3.2 Mevion Medical Systems, Inc. Business Overview
11.3.3 Mevion Medical Systems, Inc. Particle Therapy Introduction
11.3.4 Mevion Medical Systems, Inc. Revenue in Particle Therapy Business (2019-2024)
11.3.5 Mevion Medical Systems, Inc. Recent Development
11.4 Provision Healthcare, LLC
11.4.1 Provision Healthcare, LLC Company Detail
11.4.2 Provision Healthcare, LLC Business Overview
11.4.3 Provision Healthcare, LLC Particle Therapy Introduction
11.4.4 Provision Healthcare, LLC Revenue in Particle Therapy Business (2019-2024)
11.4.5 Provision Healthcare, LLC Recent Development
11.5 Sumitomo Heavy Industries, Ltd.
11.5.1 Sumitomo Heavy Industries, Ltd. Company Detail
11.5.2 Sumitomo Heavy Industries, Ltd. Business Overview
11.5.3 Sumitomo Heavy Industries, Ltd. Particle Therapy Introduction
11.5.4 Sumitomo Heavy Industries, Ltd. Revenue in Particle Therapy Business (2019-2024)
11.5.5 Sumitomo Heavy Industries, Ltd. Recent Development
11.6 Hitachi, Ltd.
11.6.1 Hitachi, Ltd. Company Detail
11.6.2 Hitachi, Ltd. Business Overview
11.6.3 Hitachi, Ltd. Particle Therapy Introduction
11.6.4 Hitachi, Ltd. Revenue in Particle Therapy Business (2019-2024)
11.6.5 Hitachi, Ltd. Recent Development
11.7 Optivus Proton Therapy, Inc.
11.7.1 Optivus Proton Therapy, Inc. Company Detail
11.7.2 Optivus Proton Therapy, Inc. Business Overview
11.7.3 Optivus Proton Therapy, Inc. Particle Therapy Introduction
11.7.4 Optivus Proton Therapy, Inc. Revenue in Particle Therapy Business (2019-2024)
11.7.5 Optivus Proton Therapy, Inc. Recent Development
11.8 Protom International, Inc.
11.8.1 Protom International, Inc. Company Detail
11.8.2 Protom International, Inc. Business Overview
11.8.3 Protom International, Inc. Particle Therapy Introduction
11.8.4 Protom International, Inc. Revenue in Particle Therapy Business (2019-2024)
11.8.5 Protom International, Inc. Recent Development
11.9 Advanced Oncotherapy PLC.
11.9.1 Advanced Oncotherapy PLC. Company Detail
11.9.2 Advanced Oncotherapy PLC. Business Overview
11.9.3 Advanced Oncotherapy PLC. Particle Therapy Introduction
11.9.4 Advanced Oncotherapy PLC. Revenue in Particle Therapy Business (2019-2024)
11.9.5 Advanced Oncotherapy PLC. Recent Development
11.10 Danfysik A/S
11.10.1 Danfysik A/S Company Detail
11.10.2 Danfysik A/S Business Overview
11.10.3 Danfysik A/S Particle Therapy Introduction
11.10.4 Danfysik A/S Revenue in Particle Therapy Business (2019-2024)
11.10.5 Danfysik A/S Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
